维普中文期刊产品整合服务
28篇 您的检索式:作者名="Moasser MM"
    题名 作者 年代 出处 被引量
1HER3 comes of age: new insights into its functions and role in signaling, tumor biology, and cancer therapy 显示文摘CAMPBELL MR AMIN D MOASSER MM 2010Clin Cancer Res2010,16,5:1
2The HER family and cancer: emerging molecular mechanisms and therapeutic targets 显示文摘Sergina NV Moasser MM 2007Trends Mol Med2007,13,12:1
3The oncogene HER2 : Its signaling and transformingfunctions and its role in human cancer pathogenesis 显示文摘Moasser MM 2007Onco- gene2007,26,45:1
4The tyrosine kinase inhibitor ZD1839 ('Iressa') inhibits HER2-driven signaling and suppresses the growth of HER2-overexpressing tumor cells显示文摘Moasser MM Basso A Averbuch SD Rosen N 2001Cancer Res2001,61,:1
5The Tyrosine Kinasse Inhibitor ZD1839 (Iressa) Inhibits HER2-driven Signaling and Suppresses the Growth of HER2-overexpressing Turner Cells显示文摘Moasser MM Basso A Averbuch SD 2001Cancer Res2001,61,19:1
6Targeting the function of the HER2 oncogene in human cancer therapeutics显示文摘Moasser MM 2007Oncogene2007,26,46:1
7The tyrosine kinase inhibitor ZD1839 ('Iressa') inhibits HER2-driven signaling and suppresses the growth of HER2-overexpressing tumor cells显示文摘Moasser MM Basso A Averbuch SD 0,,:1
8Cellular mechanisms of resistance to an- thracyclines and taxanes in cancer: Intrinsic and acquired 显示文摘Chien AJ Moasser MM 2008Semin Oncol2008,35,22:1
9Targeting the function of the HER2 oncogene in human cancer therapeutics显示文摘Moasser MM 2007Oncogene2007,26,46:1
10Inhibition of heat shock protein 90 function by ansamycins causes the morphological and functional differentiation of breast cancer cells 显示文摘Munster PN Srethapakdi M Moasser MM 2001Cancer Res2001,61,:1
11The oncogene HER2:its signaling and trans- forming functions and its role in human cancer pathogenesis 显示文摘Moasser MM 2007Oncogene2007,26,45:1
12Inhibition of heat shock protein 90 function by ansamycins causes the morphological and functional differentiation of breast cancer cells显示文摘Münster PN Srethapakdi M Moasser MM 2001Cancer Res2001,61,7:1
13The epidermal growth factor recep- tor family: biology driving targeted therapeutics 显示文摘Wieduwih M J Moasser MM 2008Cell Mol Life Sci2008,65,10:1
14The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis 显示文摘Moasser MM 2007Oncogene2007,26,45:1
15The tyrosine kinase inhibitor ZD1839 (' Iressa') inhibits HER2-driven signaling and suppresses the growth of HER2-overexpressing tumor cells显示文摘Moasser MM Basso A Averbuch SD 2001Cancer Res2001,61,19:1
16Targeting HER proteins incancer therapy and the role of non-target HER3显示文摘Hsieh AC Moasser MM 2007Br JCancer2007,97,:1
17The oncogene HER2: its signaling and trans- forming functions and its role in human cancer pathogenesis 显示文摘Moasser MM 2007Oncogene2007,26,45:1
18Cellular mechanisms of resistance to anthracyclines and taxanes in cancer:intrinsic and acquired显示文摘Chien AJ Moasser MM 2008Semin Oncol2008,35,2:1
19Targeting the function of the HER2/NEU oncogene in human cancer the rapeutics显示文摘Moasser MM 0,,46:1
20The HER family and cancer:emerging molecular mechanisms and therapeutic targets显示文摘Sergina NV Moasser MM 2007Trends MolMed2007,13,12:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费